Coala Life has announced a research and development partnership with Asahi Kasei Corporation in Japan.
The collaboration includes a development program and research targeting Heart Failure (HF) patients in Japan.
Exclusively on the Japanese market
Coala Life has partnered with Asahi Kasei Corporation exclusively on the Japanese market to further develop and evaluate the use of the Coala Heart Monitor for remote monitoring and management of patients affected by HF. The device is not approved in Japan, only used for research. The intent is to develop and evaluate novel digital biomarkers of HF and evaluate the clinical solutions in terms of service feasibility in Japan.
“We’re delighted to initiate a collaboration with Asahi Kasei to further explore the unique opportunities of our digital platform and its use in helping to remotely monitor and manage Heart Failure patients,” comments Dan Pitulia, CEO of Coala Life.
The financial terms of the collaboration are not disclosed.